ATLAS holds up 10-year tamoxifen regime

Results from the ATLAS study indicate that women with estrogen receptor-positive breast cancer should consider taking tamoxifen for up to 10 years after diagnosis.
Source: MedWire News - Breast Cancer - Category: Cancer & Oncology Source Type: news